Grow Biotech, IPS Specials join forces to offer medicinal cannabis
Category: #health  By Mateen Dalal  Date: 2019-04-02
  • share
  • Twitter
  • Facebook
  • LinkedIn

Grow Biotech, IPS Specials join forces to offer medicinal cannabis

A joint venture will combine IPS Specials’ abilities as a licensed pharma importer with medical cannabis expertise of Grow Biotech

Reports confirm that IPS Specials and Grow Biotech will ink a joint venture agreement for creating a new firm that will provide the only full licensed market access proposition of medicinal cannabis in the U.K. and transform the access to medical cannabis in U.K. and Europe.

Seemingly, the joint venture would combine market capabilities of IPS Specials as a licensed importer of pharmaceuticals with unparalleled medical cannabis expertise of Grow Biotech.

Sources familiar with the matter informed that the new company will directly benefit from IPS’ infrastructure, profound knowledge and full set of licenses. These include Home Office Controlled Drugs Schedule 2, MHRA Specials Manufacturing, and GPhC Registered Pharmacy, besides the unique offerings of Grow Biotech such as cannabis technologists, expert scientists, business developers and ABPI regulated pharmaceutical reps.

The new company will focus on maximizing and supporting patient access. The directors are already involved in advanced discussions with a huge number of leading Licensed Producers (LP), ensuring health care professionals as well as patients have access to a wide selection of the prime cannabis based medicinal products.

New company’s formation is anticipated to be completed and named by the end of this month and in the coming weeks, the very first LP partnerships will also be announced. For UK patients it will become a major part of the solution, especially those who are well treated by cannabis-based medicines.

According to the CEO of Grow Biotech, Ben Langley, through this joint venture, the new company formed with IPS Specials would be focused on positive patient outcomes. With Grow’s deep cannabis knowledge and the track record of deploying and raising capital the company is well placed to facilitate the growth in the UK.

For those uninitiated, on 15 Feb 2019, Grow Biotech and IPS Specials worked jointly to successfully implement the first bulk import of medicinal cannabis from Europe to the UK, with three patients getting their cannabis medicines within 24 hours of the cannabis arriving in the UK.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Ather Energy raises $250 million to stay ahead in competition
Ather Energy raises $250 million to stay ahead in competition
By Mateen Dalal

Electric scooter producer Ather Energy has reportedly secured $250 million in a new funding round. As per reports, the investment round is in its early stages. The company’s goal is to obtain $200 million to $250 million to compete in the EV...

Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
Digital wellness startup Mojorcare bags USD 20 Mn in Series A funding
By Mateen Dalal

Mojocare, a wellness and health startup has reportedly raised USD 20.6 million in a Series A round of funding which was led by B Capital Group and saw participation from existing investors including Sequoia India’s Surge, Better Capital, and Ch...

Exponent Energy bags USD 13 million in Lightspeed-led Series A funding
Exponent Energy bags USD 13 million in Lightspeed-led Series A funding
By Mateen Dalal

Bangalore-based Exponent Energy has reportedly secured USD 13 million in a Series A funding round which was spearheaded by Lightspeed Venture Partners. The round also saw participation from existing investors such as 3one4 Capital, YourNest VC, and A...